Social and Structural Determinants of Cardiovascular Complications of Diabetes

IF 5.2 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Current Diabetes Reports Pub Date : 2024-05-02 DOI:10.1007/s11892-024-01541-7

Portia Mensah, Kelly Valdez, Ankita Gyawali, Janet Snell-Bergeon

{"title":"Social and Structural Determinants of Cardiovascular Complications of Diabetes","authors":"Portia Mensah, Kelly Valdez, Ankita Gyawali, Janet Snell-Bergeon","doi":"10.1007/s11892-024-01541-7","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3><p>Cardiovascular disease (CVD) is the leading cause of mortality in people who have diabetes. Racial and ethnic minorities with diabetes have suboptimal management of cardiovascular risk factors, leading to higher mortality. Social and structural determinants of health are external factors that influence an individual’s ability to choose positive health behaviors. In this review, we will discuss cardiovascular complications in people who have diabetes and their relationship to social determinants of health (SDOH).</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>Recent innovations in diabetes treatment, including new devices and medications, have improved care and survival. However, disparities in the availability of these treatments to racial and ethnic minorities may contribute to continued inequities in CVD outcomes.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>Racial/ethnic disparities in CVD relate to inequities in economic opportunity, education and health literacy, neighborhoods and social cohesion, and health care access and quality driven by structural racism.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"88 1","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Diabetes Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11892-024-01541-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of Review

Cardiovascular disease (CVD) is the leading cause of mortality in people who have diabetes. Racial and ethnic minorities with diabetes have suboptimal management of cardiovascular risk factors, leading to higher mortality. Social and structural determinants of health are external factors that influence an individual’s ability to choose positive health behaviors. In this review, we will discuss cardiovascular complications in people who have diabetes and their relationship to social determinants of health (SDOH).

Recent Findings

Recent innovations in diabetes treatment, including new devices and medications, have improved care and survival. However, disparities in the availability of these treatments to racial and ethnic minorities may contribute to continued inequities in CVD outcomes.

Summary

Racial/ethnic disparities in CVD relate to inequities in economic opportunity, education and health literacy, neighborhoods and social cohesion, and health care access and quality driven by structural racism.

Abstract Image

查看原文本刊更多论文

糖尿病心血管并发症的社会和结构决定因素

综述目的心血管疾病（CVD）是糖尿病患者死亡的主要原因。少数种族和少数族裔糖尿病患者对心血管风险因素的管理不够理想，导致死亡率较高。健康的社会和结构决定因素是影响个人选择积极健康行为能力的外部因素。在这篇综述中，我们将讨论糖尿病患者的心血管并发症及其与健康的社会决定因素（SDOH）的关系。最近的研究结果最近在糖尿病治疗方面的创新，包括新的设备和药物，改善了护理和生存。摘要心血管疾病中的种族/族裔差异与结构性种族主义导致的经济机会、教育和健康知识、邻里关系和社会凝聚力以及医疗服务的获取和质量方面的不平等有关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Diabetes Reports 医学 -

CiteScore

9.80

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The goal of this journal is to publish cutting-edge reviews on subjects pertinent to all aspects of diabetes epidemiology, pathophysiology, and management. We aim to provide incisive, insightful, and balanced contributions from leading experts in each relevant domain that will be of immediate interest to a wide readership of clinicians, basic scientists, and translational investigators. We accomplish this aim by appointing major authorities to serve as Section Editors in key subject areas across the discipline. Section Editors select topics to be reviewed by leading experts who emphasize recent developments and highlight important papers published over the past year on their topics, in a crisp and readable format. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.